How far are we from a medication use process aiming at well-informed adherent patients with long-term medications in Finland? Qualitative study

被引:3
|
作者
Mononen, Niina [1 ]
Pohjanoksa-Mantyla, Marika [1 ]
Airaksinen, Marja Sa [1 ]
Hameen-Anttila, Katri [2 ]
机构
[1] Univ Helsinki, Div Pharmacol & Pharmacotherapy, Fac Pharm, Helsinki, Finland
[2] Finnish Med Agcy Fimea, Assessment Pharmacotherapies, Helsinki, Finland
来源
BMJ OPEN | 2020年 / 10卷 / 06期
关键词
PRIMARY-CARE; MEDICINES INFORMATION; HOME-CARE; INTERVENTIONS; PHARMACISTS; OPPORTUNITIES; CHALLENGES; ERRORS;
D O I
10.1136/bmjopen-2019-036526
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Finland is one of the few countries that has established a national Medicines Information (MI) Strategy. The ultimate goal of the strategy is a well-implemented medication use process resulting in well-informed adherent patients. This study aimed at evaluating the implementation of the strategy 3 years after its launch. Design The evaluation applied a pragmatic approach and was conducted by interviewing stakeholders involved in the National MI Network enhancing the MI Strategy's implementation. The network comprises national key stakeholders producing and using MI. Data were deductively analysed according to the medication use process of the MI Strategy using the framework method, complemented with inductively derived categories. Setting National implementation of the MI Strategy throughout the healthcare system after the first operational period (2012-2014) in 2015. Participants The members of the National MI Network (n=79/111, participation rate 71%, representing 42/53 stakeholder organisations). Outcome measures A new conceptual framework was developed based on stakeholders' views on wellimplemented actions and actions needing development in the medication use process at (1) infrastructure (macro), (2) healthcare professionals (mesa) and (3) patient (micro) levels. Results Medication counselling by community pharmacists was the primary implemented action, followed by physicians' actions while starting a new medication, and advice given by nurses. The major development needs concerned (1) poor access to patient information and its transfer in healthcare, particularly the lack of reconciled medication lists and electronic health records (macro); (2) poorly functioning medication use process in home care and social care units, such as nursing homes (meso); and (3) limited patient involvement in their care (micro). Conclusions Far more actions for development than well-established practices in the medication use process were identified. Major challenges found in this evaluation are considered in the ongoing Rational Pharmacotherapy Action Plan 2018-2022 by the Ministry of Social Affairs and Health.
引用
收藏
页数:11
相关论文
共 5 条
  • [1] Pharmacists' views on discontinuing long-term use of antidepressants and supporting patients during the discontinuation process: a qualitative study
    Van Leeuwen, Ellen
    Mehuys, Els
    Boussery, Koen
    Christiaens, Thierry
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2024, 74
  • [2] How do general practitioners contribute to preventing long-term work disability of their patients suffering from depressive disorders? A qualitative study
    Chantal Sylvain
    Marie-José Durand
    Pascale Maillette
    Lise Lamothe
    [J]. BMC Family Practice, 17
  • [3] How do general practitioners contribute to preventing long-term work disability of their patients suffering from depressive disorders? A qualitative study
    Sylvain, Chantal
    Durand, Marie-Jose
    Maillette, Pascale
    Lamothe, Lise
    [J]. BMC FAMILY PRACTICE, 2016, 17
  • [4] Long-term Response Rates in Chronic and Episodic Migraine Patients with Concomitant Preventive Medication Use: Results from 1-Year Study
    Goadsby, P. J.
    Silberstein, S. D.
    Dodick, D. W.
    Cohen, J. M.
    Yang, R.
    Ning, X.
    [J]. HEADACHE, 2019, 59 : 97 - 97
  • [5] General practitioners’ views on (long-term) prescription and use of problematic and potentially inappropriate medication for oldest-old patients—A qualitative interview study with GPs (CIM-TRIAD study)
    Nadine Janis Pohontsch
    Kathrin Heser
    Antje Löffler
    Britta Haenisch
    Debora Parker
    Tobias Luck
    Steffi G. Riedel-Heller
    Wolfgang Maier
    Frank Jessen
    Martin Scherer
    [J]. BMC Family Practice, 18